Text Message-Based Navigation Intervention for Malignant Solid Neoplasms

Phase-Based Progress Estimates
Emory University/Winship Cancer Institute, Atlanta, GA
Malignant Solid Neoplasms+2 More
Text Message-Based Navigation Intervention - Other
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a digital meditation can help with post-operative pain control and stress after abdominal surgery for cancer. The Text Message-Based Navigation Intervention is being trialed as a potential treatment for malignant solid neoplasms with no placebo group. The treatment is provided free of charge and can be completed online. This treatment has received FDA approval for a different condition in the past.

Eligible Conditions

  • Malignant Solid Neoplasms
  • Neoplasms

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: Up to 12 months

Up to 12 months
Feasibility of intervention and mode of delivery
Incidence of adverse events
Intervention and mode of delivery utilizing the Client Satisfaction Survey (CSQ-8)
Intervention and mode of delivery utilizing the System Usability Scale (SUS)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Arm I (Pain Survey)
1 of 2
Arm 2 (Mindfulness Intervention)
1 of 2
Active Control
Experimental Treatment

30 Total Participants · 2 Treatment Groups

Primary Treatment: Text Message-Based Navigation Intervention · No Placebo Group · Phase < 1

Arm 2 (Mindfulness Intervention)Experimental Group · 2 Interventions: Text Message-Based Navigation Intervention, Interview · Intervention Types: Other, Other
Arm I (Pain Survey)ActiveComparator Group · 2 Interventions: Survey Administration, Interview · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12 months
Closest Location: Emory University/Winship Cancer Institute · Atlanta, GA
Photo of Atlanta 1Photo of Atlanta 2Photo of Atlanta 3
2011First Recorded Clinical Trial
2 TrialsResearching Malignant Solid Neoplasms
60 CompletedClinical Trials

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
12,937 Previous Clinical Trials
41,301,975 Total Patients Enrolled
106 Trials studying Malignant Solid Neoplasms
193,360 Patients Enrolled for Malignant Solid Neoplasms
Emory UniversityLead Sponsor
1,498 Previous Clinical Trials
2,666,297 Total Patients Enrolled
1 Trials studying Malignant Solid Neoplasms
10 Patients Enrolled for Malignant Solid Neoplasms
Maggie Diller, MDPrincipal InvestigatorEmory University/Winship Cancer Institute

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You own a smartphone with SMS texting capabilities.
You are able to read and write.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.